XML 23 R10.htm IDEA: XBRL DOCUMENT v3.23.2
EARNINGS PER SHARE
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
EARNINGS (LOSS) PER SHARE EARNINGS PER SHARE
    The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):
Three Months Ended June 30,Six Months Ended June 30,
 2023202220232022
Amounts attributable to Quest Diagnostics’ common stockholders:    
Net income attributable to Quest Diagnostics$235 $234 $437 $589 
Less: Earnings allocated to participating securities
Earnings available to Quest Diagnostics’ common stockholders – basic and diluted
$234 $233 $435 $587 
Weighted average common shares outstanding – basic112 117 112 118 
Effect of dilutive securities:    
Stock options and performance share units
Weighted average common shares outstanding – diluted114 119 114 120 
Earnings per share attributable to Quest Diagnostics’ common stockholders:    
Basic$2.08 $2.00 $3.88 $4.97 
Diluted$2.05 $1.96 $3.83 $4.88 
    
    The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Stock options and performance share units— — —